423 related articles for article (PubMed ID: 30626205)
1. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.
Lee GL; Yeh CC; Wu JY; Lin HC; Wang YF; Kuo YY; Hsieh YT; Hsu YJ; Kuo CC
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):432-445. PubMed ID: 30626205
[TBL] [Abstract][Full Text] [Related]
2. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M
J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764
[TBL] [Abstract][Full Text] [Related]
3. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
Di Bartolo BA; Cartland SP; Harith HH; Bobryshev YV; Schoppet M; Kavurma MM
PLoS One; 2013; 8(9):e74211. PubMed ID: 24040204
[TBL] [Abstract][Full Text] [Related]
4. Restoration of 5-methoxytryptophan protects against atherosclerotic chondrogenesis and calcification in ApoE
Lee GL; Liao TL; Wu JY; Wu KK; Kuo CC
J Biomed Sci; 2021 Nov; 28(1):74. PubMed ID: 34749728
[TBL] [Abstract][Full Text] [Related]
5. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
[TBL] [Abstract][Full Text] [Related]
6. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
[TBL] [Abstract][Full Text] [Related]
7. PKA-induced receptor activator of NF-kappaB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification.
Tseng W; Graham LS; Geng Y; Reddy A; Lu J; Effros RB; Demer L; Tintut Y
J Biol Chem; 2010 Sep; 285(39):29925-31. PubMed ID: 20663885
[TBL] [Abstract][Full Text] [Related]
8. Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.
Byon CH; Sun Y; Chen J; Yuan K; Mao X; Heath JM; Anderson PG; Tintut Y; Demer LL; Wang D; Chen Y
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1387-96. PubMed ID: 21454810
[TBL] [Abstract][Full Text] [Related]
9. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.
Carrillo-López N; Martínez-Arias L; Alonso-Montes C; Martín-Carro B; Martín-Vírgala J; Ruiz-Ortega M; Fernández-Martín JL; Dusso AS; Rodriguez-García M; Naves-Díaz M; Cannata-Andía JB; Panizo S
Nephrol Dial Transplant; 2021 Mar; 36(4):618-631. PubMed ID: 33367746
[TBL] [Abstract][Full Text] [Related]
10. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification.
Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L
Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243
[TBL] [Abstract][Full Text] [Related]
11. The P2Y
Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI
Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380
[TBL] [Abstract][Full Text] [Related]
12. Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification.
Di Bartolo BA; Schoppet M; Mattar MZ; Rachner TD; Shanahan CM; Kavurma MM
Cardiovasc Res; 2011 Aug; 91(3):537-45. PubMed ID: 21447702
[TBL] [Abstract][Full Text] [Related]
13. Vanadium Derivative Exposure Promotes Functional Alterations of VSMCs and Consequent Atherosclerosis via ROS/p38/NF-κB-Mediated IL-6 Production.
Yeh CC; Wu JY; Lee GL; Wen HT; Lin P; Kuo CC
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817202
[TBL] [Abstract][Full Text] [Related]
14. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction.
Fernández-Villabrille S; Martín-Vírgala J; Martín-Carro B; Baena-Huerta F; González-García N; Gil-Peña H; Rodríguez-García M; Fernández-Gómez JM; Fernández-Martín JL; Alonso-Montes C; Naves-Díaz M; Carrillo-López N; Panizo S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891922
[TBL] [Abstract][Full Text] [Related]
15. SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.
Voelkl J; Luong TT; Tuffaha R; Musculus K; Auer T; Lian X; Daniel C; Zickler D; Boehme B; Sacherer M; Metzler B; Kuhl D; Gollasch M; Amann K; Müller DN; Pieske B; Lang F; Alesutan I
J Clin Invest; 2018 Jul; 128(7):3024-3040. PubMed ID: 29889103
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.
Bennett BJ; Scatena M; Kirk EA; Rattazzi M; Varon RM; Averill M; Schwartz SM; Giachelli CM; Rosenfeld ME
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2117-24. PubMed ID: 16840715
[TBL] [Abstract][Full Text] [Related]
17. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K2 can suppress the expression of Toll-like receptor 2 (TLR2) and TLR4, and inhibit calcification of aortic intima in ApoE
Wang Z; Wang Z; Zhu J; Long X; Yan J
Vascular; 2018 Feb; 26(1):18-26. PubMed ID: 28587577
[TBL] [Abstract][Full Text] [Related]
19. The function and meaning of receptor activator of NF-κB ligand in arterial calcification.
Nie B; Zhou SQ; Fang X; Zhang SY; Guan SM
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):666-671. PubMed ID: 26489619
[TBL] [Abstract][Full Text] [Related]
20. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet.
Sommerville LJ; Kelemen SE; Ellison SP; England RN; Autieri MV
Atherosclerosis; 2012 Jan; 220(1):45-52. PubMed ID: 21862018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
